Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis treated for up to 5 years in the PHOENIX 1 study.
Kimball, A B, K A Papp, Y Wasfi, D Chan, R Bissonnette, H Sofen, N Yeilding, et al. 2013. “Long-Term Efficacy of Ustekinumab in Patients With Moderate-to-Severe Psoriasis Treated for up to 5 Years in the PHOENIX 1 Study.”. Journal of the European Academy of Dermatology and Venereology : JEADV 27 (12): 1535-45.